EC Mark Approval
Hera-MI received EC mark approvalView more
The main purpose of Hera-MI is to use Artificial Intelligence (AI) to help early-stage breast cancer diagnosis in order to optimize patient care and save millions of women worldwide.
Our ambition is to speed up and improve breast cancer diagnosis thanks to the development of clinical decision support solutions.
Hera-MI has developed Breast-SlimView, a patented clinical decision support solution for 2D/3D mammography.
Free yourselves from irrelevant information
and detect suspicious areas at a glance
A patented clinical decision solution
for 2D/3D mammography
A faster and improved breast cancer diagnosis